Persistence of adverse effects for up to 10 years after treatment for localized prostate cancer

A new article just published by Taylor et al. in the Journal of Clinical Oncology provides detailed information about the persistence of clinically significant, long-term, prostate cancer-specific, treatment-related sexual and urinary adverse effects up to 10 years post-diagnosis. Coverage of this article also appears in a report on Reuters.com. … READ MORE …